Arbutus Biopharma's earnings of $0.02 surpassed expectations, while profits fell short of forecasts.

According to Arbutus Biopharma's (NASDAQ: ABUS) report, the earnings per share for the first quarter was -$0.070, which is $0.02 better than analysts' expectations of -$0.086. The reported earnings for this quarter amounted to $1.57M, slightly below the analysts' forecast of $1.58M.

Arbutus Biopharma's stock closed at $3.35, reflecting a remarkable 4,360% increase over the past three months and a 29,840% rise over the past year. In the last 90 days, the company has reported 0 positive earnings per share and 2 negative earnings per share. For insights into how Arbutus Biopharma's stock price reacted to past earnings reports, check here. According to InvestingPro, the company's financial health score is rated as "very good." For the latest earnings reports and comprehensive financial information about Arbutus Biopharma, visit here. Stay updated on all developments regarding balance sheets by visiting the Investing.com Earnings Calendar.